Health
Clinical study boosts Proteomics kidney test – The West Australian
Medical technology company, Proteomics International says a US clinical utility study on its PromarkerD predictive test for diabetic…
Medical technology innovator Proteomics says a US clinical utility study on its PromarkerD predictive test for diabetic kidney disease has shown the test to be more important to a physician who is monitoring a patients condition than the existing standard…
Continue Reading
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business15 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?